NAVX-010-Phase I Tolerability and Pharmacokinetic Study in Healthy Male Subjects
Clinical trial NCT03655522 · COMPLETED
Trial details
- NCT number
- NCT03655522
- Sponsor
- Algenis SpA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-14
- Primary completion
- 2015-09-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.